Published in Clin Oncol (R Coll Radiol) on September 13, 2009
Prognosis of patients with triple-negative breast cancer and brain metastasis. Clin Oncol (R Coll Radiol) (2009) 1.39
Malignancies after rituximab treatment: just coincidence or more? J BUON (2011) 1.05
The prognostic impact of obesity on molecular subtypes of breast cancer in premenopausal women. J BUON (2013) 0.96
Demographic, clinical, and pathological characteristics of Turkish triple-negative breast cancer patients: single center experience. Ann Oncol (2007) 0.92
Isolated metastasis of malignant melanoma into follicular carcinoma of the thyroid gland. J Endocrinol Invest (2004) 0.86
Adult Langerhans' cell histiocytosis: a rare cause of parotid gland enlargement. J BUON (2013) 0.84
ERCC1 expression in triple negative breast cancer. J BUON (2012) 0.84
Efficacy of adjuvant aromatase inhibitor in hormone receptor-positive postmenopausal breast cancer patients according to the body mass index. Br J Cancer (2012) 0.83
Clinical and pathological characteristics of occult breast cancer and review of the literature. J BUON (2011) 0.83
Temozolomide-related infections: review of the literature. J BUON (2011) 0.81
Impact of the obesity on lymph node status in operable breast cancer patients. J BUON (2013) 0.81
Successful treatment of primary duodenal carcinoma with bilateral adrenal metastases with docetaxel-cisplatin-5-fluorouracil regimen. Ann Oncol (2009) 0.81
Metabolic syndrome and breast cancer: an overview. J BUON (2012) 0.80
Variations in tumor marker levels in metastatic breast cancer patients according to tumor subtypes. J BUON (2013) 0.79
Comparative efficacy study of 5-year letrozole or anastrozole in postmenopausal hormone receptor-positive early breast cancer. J BUON (2013) 0.79
Promising therapeutic options in triple-negative breast cancer. J BUON (2012) 0.79
Ipsilateral axillary recurrence of breast cancer 22 years after primary surgery: the latest recurrence in the literature. J BUON (2011) 0.78
Nasopharyngeal carcinoma with synchronous breast cancer; possible role of Epstein-Barr virus infection in the carcinogenesis of both cancers. J BUON (2012) 0.78
Taxanes in the adjuvant treatment of node-negative breast cancer patients. J BUON (2012) 0.78
Human papilloma virus and breast cancer. Br J Cancer (2006) 0.78
Secondary hematological malignancies after treatment of non-metastatic breast cancer. J BUON (2012) 0.77
Transfusion-transmitted virus prevalence in subjects at high risk of sexually transmitted infection in Turkey. Clin Microbiol Infect (2002) 0.77
Does trastuzumab-emtansine have better cardiac safety profile in contrast to trastuzumab? J BUON (2013) 0.77
Short-term quinolones for successful eradication of multiply resistant Vibrio cholerae in adult patients. Scand J Infect Dis (1995) 0.77
Late recurrence of granulosa cell tumor of the ovary with synchronous gastric signet-ring cell carcinoma. J BUON (2011) 0.77
Differential alteration of drug-metabolizing enzyme activities after cyclophosphamide/adriamycin administration in breast cancer patients. Methods Find Exp Clin Pharmacol (2007) 0.77
Medullary carcinoma of the breast: a brief report from a tertiary care center. J BUON (2013) 0.77
Cyclooxygenase-2 inhibitor and cisplatin combination as a radiosensitizer in the treatment of head and neck cancer patients. Ann Oncol (2004) 0.77
ABO and Rh blood groups frequency in women with HER2 positive breast cancer. J BUON (2012) 0.77
Association between family history and clinicopathologic characteristics in 1987 breast cancer patients: single institution experience from Turkey. J BUON (2013) 0.76
An alternative way for the evaluation of zinc status in the elderly; nail zinc levels and relationship with Alzheimer's disease. Eur Rev Med Pharmacol Sci (2013) 0.76
The effect of urea on the structure of water: a molecular dynamics simulation. J Phys Chem B (2010) 0.76
Mechanisms behind the aspirin use and decreased breast cancer incidence. J BUON (2011) 0.76
Promotion of neurogenesis by human stem cells in high-risk breast cancer survivals after stem-cell supported high-dose therapy. Ann Oncol (2006) 0.75
Bone morphogenetic proteins and zoledronic acid. Ann Oncol (2009) 0.75
Percentage of family history of cancer in patients with breast cancer: Is it changing with ethnicity? J BUON (2011) 0.75
Long-term survivors among breast cancer patients with brain metastases. Ann Oncol (2009) 0.75
Obesity may decrease the amenorrhea associated with chemotherapy in premenopausal breast cancer patients. Ann Oncol (2005) 0.75
Late local recurrences in a randomized trial comparing conservative treatment with total mastectomy in early breast cancer patients: the impact of receptor status on local relapse. Ann Oncol (2004) 0.75
Is initially metastatic breast carcinoma different from recurrent metastatic breast carcinoma? Ann Oncol (2008) 0.75
Vitamin D intake may be effective in the management of triple-negative breast cancer. J BUON (2011) 0.75
How can we use anthracylines in the management of newly diagnosed metastatic breast cancer patients overexpressing HER-2? Ann Oncol (2008) 0.75
Myasthenic crisis following cisplatin chemotherapy in a patient with malignant thymoma. J Exp Clin Cancer Res (2004) 0.75
Joint problems in breast cancer patients receiving adjuvant aromatase inhibitor. J BUON (2013) 0.75
Granulocyte colony stimulating factor-induced tumor lysis-like syndrome: leucolysis. J BUON (2013) 0.75
Vemurafenib-induced hypertension: is it real? J BUON (2013) 0.75
Frequency of thyroid disease among breast cancer patients: a descriptive study of breast cancer patients. J BUON (2013) 0.75
Pure mucinous carcinoma of the breast: a single center experience. J BUON (2011) 0.75
Medullary carcinoma of the breast: a brief report from a tertiary care center. J BUON (2012) 0.75
Cyclooxygenase inhibitors may be more effective in hormone-dependent endometrial cancers: interaction between cyclooxygenase and aromatase. Ann Oncol (2005) 0.75
Clinical and pathological characteristics of very young breast cancer patients (≤ 25 years of age). J BUON (2011) 0.75
Distribution of breast cancer diagnosis according to month of birth in Turkish population. J BUON (2012) 0.75
Successful treatment of benign metastasizing leiomyoma with oral alternated chemotherapeutic agents. J BUON (2013) 0.75
Skin metastasis of ovarian cancer: a rare entity. J BUON (2010) 0.75
Triple negative endometrial cancer may be more sensitive to platinum based chemotherapy. J BUON (2013) 0.75
Synchronous presentation of breast cancer and hepatocellular carcinoma in a postmenopausal woman: dual action of aromatase inhibitor on breast and hepatic cancer cells? J BUON (2012) 0.75
How addition of capecitabine might be more beneficial in the neoadjuvant treatment of breast cancer. J BUON (2011) 0.75
Synchronous ovarian cancer in a patient with pleomorphic lobular breast cancer: a therapeutic dilemma. Clin Oncol (R Coll Radiol) (2009) 0.75
Comparison of clinicopathological characteristics and outcome of younger and older breast cancer patients. J BUON (2013) 0.75
BRCA-deficient and triple negative breast cancers: is olaparib effective in both subtypes? J BUON (2011) 0.75
Colon involvement in a chronic lymphocytic leukemia patient. J BUON (2013) 0.75
Clinical and pathological characteristics of patients 80 years and older with breast cancer. J BUON (2012) 0.75
Electrolyte abnormalities due to irinotecan administration in metastatic HER-2 positive breast cancer patients. J BUON (2013) 0.75
Old school regimen may turn the tide in metastatic breast cancer. J BUON (2012) 0.75
A case of familial nasopharyngeal carcinoma: is screening necessary for siblings? J BUON (2012) 0.75
Pathological characteristics of very young (< or = 30 years) breast cancer patients: a single-institution experience from Turkey. Ann Oncol (2009) 0.75
Breast cancer in octogenarian women: clinical characteristics and outcome. J BUON (2013) 0.75
Tumor heparanase expression in predicting response to induction chemotherapy in patients with locally advanced laryngeal cancer. J BUON (2012) 0.75
Successful treatment of myeloid sarcoma with local treatment modalities: the longest overall survival in published literature. J BUON (2014) 0.75
Progressive ascending paraparesia in an acute lymphoblastic leukemia patient: masked but not fallacious. J Exp Clin Cancer Res (2004) 0.75